Not applicableStudy completedNCT02539368
What this trial is testing
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
Who this might be right for
Inflammatory Bowel DiseasesUlcerative ColitisCrohn's Disease
Pfizer 2,565